The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation (Q108784177)

From Wikidata

Jump to navigation Jump to search

scholarly article by Zhihua Bai published in June 2021

Language	Label	Description	Also known as
English	The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation	scholarly article by Zhihua Bai published in June 2021

Statements

scholarly article

0 references

0 references

The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation (English)

0 references

1 reference

based on heuristic

inferred from title

nucleocapsid protein [SARS-CoV-2]

1 reference

based on heuristic

inferred from abstract

author name string

Zhihua Bai

1

0 references

Ying Cao

2

0 references

Wenjun Liu

3

0 references

Jing Li

4

0 references

publication date

10 June 2021

0 references

0 references

13

0 references

6

0 references

1115

0 references

copyright license

Creative Commons Attribution 4.0 International

10 June 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Serological assays for emerging coronaviruses: challenges and pitfalls

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

SARS and MERS: recent insights into emerging coronaviruses

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Coronavirus avian infectious bronchitis virus

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Virus factories: associations of cell organelles for viral replication and morphogenesis

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Effects of a SARS-associated coronavirus vaccine in monkeys.

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Structural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral Target

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Type 1 interferons and the virus-host relationship: a lesson in détente .

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging.

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Modular organization of SARS coronavirus nucleocapsid protein

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Disappearance of antibodies to SARS-associated coronavirus after recovery

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

A new coronavirus associated with human respiratory disease in China

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

RNA polymerase II clustering through carboxy-terminal domain phase separation

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Case Report of Transmissible Gastroenteritis Coronavirus Infection Associated with Small Intestine and Brain Lesions in Piglets

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Measles virus nucleo- and phosphoproteins form liquid-like phase-separated compartments that promote nucleocapsid assembly

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The SARS-CoV-2 N protein is a good component in a vaccine

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

COVID-19: discovery, diagnostics and drug development

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The SARS-CoV-2 Vaccine Pipeline: an Overview

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Role of IFN and Complements System: Innate Immunity in SARS-CoV-2

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging.

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Functional Implications of Intracellular Phase Transitions.

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers.

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Antiviral RNA interference in mammals

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Analysis of multimerization of the SARS coronavirus nucleocapsid protein

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Small molecules for modulating protein driven liquid-liquid phase separation in treating neurodegenerative disease

1 reference

https://api.crossref.org/works/10.3390/V13061115

3 October 2021

Identifiers

10.3390/V13061115

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q108784177&oldid=2129528428"